Evidence map›Paper›PMID 25042097›Full record

ReviewNatural product reports2014

The ever-expanding role of asymmetric covalent organocatalysis in scalable, natural product synthesis.

Mikail E Abbasov, Daniel Romo

Abstract readReview
In one paragraph

Review in Natural product reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mikail E AbbasovDepartment of Chemistry, Texas A&M University, P.O. Box 30012, College Station, Texas, United States. mikail.abbasov@chem.tamu.edu.
Daniel Romo

Funding

Monitoring Community Trends in Heart FailureR37HL069874 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLDBERG, ROBERT JOEL · 2002 to 2011
$6.7M
Synthetic/Mechanistic Studies of Bioactive Marine AgentsR37GM052964 · NIGMS · TEXAS A&M UNIVERSITY · PI ROMO, DANIEL · 2009 to 2019
$3.6M
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTSR01GM052964 · NIGMS · TEXAS A&M UNIVERSITY SYSTEM · PI ROMO, DANIEL · 2000 to 2008
$2.4M
NHLBI NIH HHS R37 HL069874NIGMS NIH HHS R01 GM052964NIGMS NIH HHS R37 GM052964NIGMS NIH HHS R37 GM069874
6 · The paper itself

Abstract

Following the turn of the millennium, the role of asymmetric covalent organocatalysis has developed into a scalable, synthetic paradigm galvanizing the synthetic community toward utilization of these methods toward more practical, metal-free syntheses of natural products. A myriad of reports on asymmetric organocatalytic modes of substrate activation relying on small, exclusively organic molecules are delineating what has now become the multifaceted field of organocatalysis. In covalent catalysis, the catalyst and substrate combine to first form a covalent, activated intermediate that enters the catalytic cycle. Following asymmetric bond formation, the chiral catalyst is recycled through hydrolysis or displacement by a pendant group on the newly formed product. Amine- and phosphine-based organocatalysts are the most common examples that have led to a vast array of reaction types. This Highlight provides a brief overview of covalent modes of organocatalysis and applications of scalable versions of these methods applied to the total synthesis of natural products including examples from our own laboratory.

Indexed as

Biological ProductsCatalysisMolecular StructureBiological Products

Identifiers

PMID25042097
PMCPMC5470744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.